Background: Despite tremendous evolution in therapies. the prognosis of glioblastoma (GBM) remains grim. which calls for innovative approaches to optimize chemotherapy efficacy and predict risk. Methods: The transcriptome and clinical data of GBM were acquired from the Cancer Genome Atlas (TCGA). https://sportshutes.shop/product-category/chargers/